Michael H. Davidson - 20 Aug 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role: Chief Executive Officer, Director
Signature: /s/ Michael H. Davidson
Issuer symbol: NAMS
Transactions as of: 20 Aug 2024
Net transactions value: +$81,350
Form type: 4
Filing time: 22 Aug 2024, 16:30:12 UTC
Previous filing: 08 Aug 2024
Next filing: 25 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAMS	Ordinary Shares	Purchase	$81,350	+5,000	+2.4%	$16.27	209,784	20 Aug 2024	Direct
holding	NAMS	Ordinary Shares						608,779	20 Aug 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 608,779 Ordinary Shares are held of record by Stichting Administratiekantoor EPNAP ("STAK EPNAP") and are subject to forfeiture underlying depositary receipts issued by STAK EPNAP. STAK EPNAP has sole voting and investment power over the 608,779 Ordinary Shares underlying the depositary receipts and are presented here because the depositary receipts can be cancelled by the board of directors of STAK EPNAP at any time as a consequence of which the Reporting Person will become the beneficial owner of the securities underlying the depositary receipts.

Content

The 608,779 Ordinary Shares are held of record by Stichting Administratiekantoor EPNAP ("STAK EPNAP") and are subject to forfeiture underlying depositary receipts issued by STAK EPNAP. STAK EPNAP has sole voting and investment power over the 608,779 Ordinary Shares underlying the depositary receipts and are presented here because the depositary receipts can be cancelled by the board of directors of STAK EPNAP at any time as a consequence of which the Reporting Person will become the beneficial owner of the securities underlying the depositary receipts.